Saturday 17 October 2026 Export LXRX’s income statement to Excel — free account

Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $49.8 million, up 60.2% from fiscal 2024. In the quarter to June 2026, revenue fell 97.6%, EPS fell 800.0%, free cash flow fell 154.1% and total debt fell 8.32%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

1.52 0.13 −7.88%

Follow LXRX

Alert me

Market cap: $734.2M
P/E: 0.0×
Fwd P/E: −12.1×
Dividend yield: —
F-score: 4/9
Altman Z: −12.11
Beneish M: −1.17
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	0.00	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	25.33	8.97	8.38	6.92
P/FCF ratio Full definition →	0.00	0.00	0.00	0.00
P/Operating CF Full definition →	(114.27)	(42.39)	(24.23)	(20.58)
P/B ratio Full definition →	6.02	3.08	3.88	4.08
Price to Tangible BV Full definition →	8.08	3.94	6.63	6.49
EV/Sales Full definition →	22.08	7.29	7.54	6.68
EV/EBITDA Full definition →	0.00	0.00	0.00	0.00
EV/Operating CF Full definition →	(14.09)	(13.09)	(5.53)	(6.56)
EV/FCF Full definition →	(13.87)	(12.75)	(5.45)	(6.47)
Quick Ratio Full definition →	13.07	18.43	4.73	5.45
Current Ratio Full definition →	13.37	18.79	4.88	5.64
Net Debt/EBITDA Full definition →	5.37	590.12	2.98	5.11
Debt/Assets Full definition →	20.57%	18.48%	29.19%	27.44%
Debt/Equity Full definition →	0.29	0.24	0.50	0.47
Asset Turnover Full definition →	0.17	0.25	0.21	0.27
Operating CF/Net income Full definition →	0.29	14.12	1.11	1.87
Capex/Depreciation Full definition →	0.00	0.00	0.00	0.00
Interest Coverage Full definition →	(10.17)	(0.63)	(7.28)	(5.66)
Research and Development Expense of Revenue Full definition →	2,520.66%	60.45%	205.97%	132.26%
Selling, General and Administrative Expense of Revenue Full definition →	1,408.96%	43.76%	159.46%	53.60%
Intangible Assets out of Total Assets Full definition →	0.18	0.17	0.24	0.22
Share Based Compensation of Revenue Full definition →	482.08%	14.59%	51.61%	24.28%
Graham Net Nets Full definition →	0.12	0.19	0.06	0.07
Graham Number Full definition →	0.00	0.00	0.00	0.00
Earnings Yield Full definition →	(6.36%)	(4.65%)	(12.17%)	(14.07%)
Free Cash Flow Yield Full definition →	(6.29%)	(6.38%)	(16.50%)	(14.91%)
Revenue per Share Full definition →	0.00	0.05	0.02	0.04
Operating CF per Share Full definition →	(0.02)	(0.04)	(0.05)	(0.07)
Capex per Share Full definition →	0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →	(0.02)	(0.04)	(0.05)	(0.07)
Cash per Share Full definition →	0.44	0.43	0.27	0.32
Shareholders Equity per Share Full definition →	0.40	0.51	0.30	0.33
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	0.40	0.51	0.30	0.33
Free Cash Flow Full definition →	(9.19)	(14.73)	(17.23)	(23.83)
Working Capital Full definition →	181.87	176.13	81.03	100.81
Net Current Asset Value Full definition →	121.04	120.07	24.45	36.76
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	1.91	29.61	2.93	2.61
Average Payables Full definition →	4.12	6.84	8.94	9.00
Average Inventory Full definition →	0.68	0.24	0.26	0.40
Average Assets Full definition →	237.82	283.25	241.70	263.53
Average Common Equity Full definition →	151.98	162.94	126.74	149.34

Show all line items

Columns are period end dates

Stockrow Weekly